Dogwood Therapeutics
DWTX
13 hedge funds and large institutions have $410K invested in Dogwood Therapeutics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
436% more capital invested
Capital invested by funds: $76.5K → $410K (+$333K)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
1.98% more ownership
Funds ownership: 2.31% → 4.29% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$84.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$82.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$79.8K |
| 4 |
HF
HRT Financial
New York
|
+$76K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$949 |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$244 |
DWTX Hedge Fund Activity: Q1 2025 in Review
13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2025, worth a combined $410K — up 436% from $76.5K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DWTX positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $84.6K. The largest seller was Northwestern Mutual Wealth Management, exiting entirely with an estimated $949 sold.
- 13 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2025, up from 10 in Q4 2024.
- Funds reported $410K of Dogwood Therapeutics stock for Q1 2025, up 436% quarter-over-quarter.
- 4 funds opened new Dogwood Therapeutics positions in Q1 2025 and 1 closed out, a net change of +3 holders.
- The largest Dogwood Therapeutics buyer in Q1 2025 was FNY Investment Advisers, an estimated $84.6K added.
- The largest Dogwood Therapeutics seller in Q1 2025 was Northwestern Mutual Wealth Management, an estimated $949 sold.
Based on aggregated 13F filings for Q1 2025.